NASDAQ •
Healthcare •
Drug Manufacturers - General •
Quote as of 05/12/2026 16:00
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeNASDAQ
Market Capitalization103,764 mln
Float1,087 mln
Earnings Date07/23/2026
EPS
2.33
Solid
P / E
18.39
Moderately valued
Piotroski F-Score
7
/ 9
Strong
Beneish M-Score
-2.45
Borderline
1-Year Forecast
55.90
Strong upside
Relative Strength
27
/ 100
Underperforming
Business Description
Sanofi is a Paris-based global pharmaceutical company founded in 1994 that researches, develops, and sells treatments across a wide range of medical areas, including rare diseases, cancer, neurology, and immune conditions, as well as a broad portfolio of vaccines. The company works with numerous partners to advance next-generation therapies, including AI-driven drug discovery, protein degradation treatments, genome editing, and antibody-based medicines. Through these collaborations, Sanofi aims to bring meaningful new treatment options to patients around the world.